TH
Trung Huynh RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
14%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
60%
Neutral
36%
Negative
4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Underperform
Initiated
| $25 |
7%
downside
| 3 | +1.7% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $1,250 |
41%
upside
| 4 | +8.3% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
|
Sector Perform
Initiated
| $60 |
2%
upside
| 2 | – |
–
| 25 Feb ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $260 |
31%
upside
| 1 | -2.8% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $142 |
27%
upside
| 2 | +3.6% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
|
Neutral
Maintained
| $660 |
12%
downside
| 4 | – |
–
| 7 Nov ‘25 5 months ago |
|
|
|
Buy
Maintained
| $223 |
65%
upside
| 5 | +21% |
0
%
| 31 Oct ‘25 5 months ago |
|
|
|
Buy
Maintained
| $25 |
2,882%
upside
| 2 | -48% |
0
%
| 15 Aug ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $317 |
8%
downside
| 3 | – |
–
| 6 Aug ‘25 8 months ago |
|
|
|
Buy
Maintained
| $38 |
14%
upside
| 1 | +56% |
0
%
| 9 May ‘25 11 months ago |
|